Article

Challenges, Difficulties, and Delayed Diagnosis of Multiple Myeloma

2025-05-02

Abstract excerpt

<h4>Background: </h4> Multiple myeloma (MM) is a heterogenous plasma cell malignancy with non-specific symptoms and disease heterogeneity at clinical and biological levels. This non-specific set of symptoms, including bone pain, anemia, renal failure, hypercalcemia, and neuropathy can mislead diagnosis as chronic or benign conditions, resulting in a delay in diagnosis. Timely identification is paramount to prevent...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1f2e2f93-0414-57e4-8785-d79061cb3e21
DOI: 10.20944/preprints202505.0092.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Challenges, Difficulties, and Delayed Diagnosis of Multiple MyelomaDOI 10.20944/preprints202505.0092.v1Read

SnapShot: Multiple Myeloma.Semantic proximity Read

Non-secretory multiple myeloma: from biology to clinical managementSemantic proximity Read

Epidemiology, genetics and treatment of multiple myeloma and precursor diseases.Semantic proximity Read

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaSemantic proximity Read

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.Semantic proximity Read

High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitionsSemantic proximity Read

Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects.Semantic proximity Read

Quantitative Imaging and Radiomics in Multiple Myeloma: opportunity or hype?Semantic proximity Read

Interpretation of cytogenetic results in multiple myeloma for clinical practiceSemantic proximity Read

Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profilingSemantic proximity Read

Pathophysiological underpinnings of multiple myeloma progression.Semantic proximity Read

Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic useSemantic proximity Read